Your Advocates Ltd’s Johnson & Johnson JNJ Stock Holding History

Your Advocates Ltd’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-60	Closed	-$9.93K	–	328
2023 Q2	$9.93K	Buy	+60	New	+$9.68K	0.01%	134

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Your Advocates Ltd's JNJ Position: Q3 2023 in Review

Your Advocates Ltd sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 60 shares — an estimated $9.93K sold.

Your Advocates Ltd first reported a position in JNJ in Q2 2023 and held it in 1 quarter. The position peaked at $9.93K in Q2 2023. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

Your Advocates Ltd reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
Your Advocates Ltd sold 60 Johnson & Johnson shares in Q3 2023, an estimated $9.93K.
Your Advocates Ltd first reported a position in Johnson & Johnson in Q2 2023 and held it in 1 quarter.
Your Advocates Ltd's Johnson & Johnson position peaked at $9.93K in Q2 2023.
3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Your Advocates Ltd's 13F filing for Q3 2023, filed 2 Nov 2023.